Cargando…

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma

BACKGROUND: Increasing evidence exists of a link between DNA methylation and tumor immunotherapy. However, the impact of DNA methylation on the characteristics of the lung adenocarcinoma microenvironment and its effect on immunotherapy remain unclear. METHOD: This study collected TCGA-LUAD related d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pengli, Xu, Gaoran, Gao, Erji, Xu, Yong, Liang, Leilei, Jiang, Gening, Duan, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259289/ https://www.ncbi.nlm.nih.gov/pubmed/35814273 http://dx.doi.org/10.1155/2022/8802303

Ejemplares similares

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019)

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method
por: Cai, Qidong, et al.
Publicado: (2020)

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung
por: He, Si-Yu, et al.
Publicado: (2019)

Identification of an eight-gene prognostic signature for lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma
por: Ye, Jing, et al.
Publicado: (2019)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
por: Chen, Qinjunjie, et al.
Publicado: (2020)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma
por: Dong, Min, et al.
Publicado: (2020)

Identification of DNA methylation prognostic signature of acute myelocytic leukemia
por: Zhang, Haiguo, et al.
Publicado: (2018)

Identification of a novel endocytosis‑associated gene signature for prognostic prediction in lung adenocarcinoma
por: Zhang, Yixin, et al.
Publicado: (2023)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
por: Yue, Cheng, et al.
Publicado: (2019)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma
por: Wang, Yuzhu, et al.
Publicado: (2022)

Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma
por: Han, Liankui, et al.
Publicado: (2018)

Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma
por: Liao, Hongying, et al.
Publicado: (2022)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

Clustering analysis and prognostic signature of lung adenocarcinoma based on the tumor microenvironment
por: Shan, Qingqing, et al.
Publicado: (2022)

Prognostic value of surgical intervention in advanced lung adenocarcinoma: a population-based study
por: Zhu, Shuncang, et al.
Publicado: (2021)

Identification of prognostic signature in cancer based on DNA methylation interaction network
por: Hu, Wei-Lin, et al.
Publicado: (2017)

DNA methylation profiling analysis identifies a DNA methylation signature for predicting prognosis and recurrence of lung adenocarcinoma
por: Wang, Rui, et al.
Publicado: (2019)

Identification and validation of GABA‐driven subtypes and prognosis signature of lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2023)

Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma
por: Guo, Yugang, et al.
Publicado: (2021)

Prognostic Significance of PTTG1 and Its Methylation in Lung Adenocarcinoma
por: Bai, Lu, et al.
Publicado: (2022)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of a prognostic signature and ENTR1 as a prognostic biomarker for colorectal mucinous adenocarcinoma
por: Huang, An, et al.
Publicado: (2023)

Identification and validation of a novel prognostic model of inflammation-related gene signature of lung adenocarcinoma
por: Luo, Dayuan, et al.
Publicado: (2022)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)

Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma
por: Sun, Lei, et al.
Publicado: (2020)

Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma
por: Zhu, Jing, et al.
Publicado: (2021)

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
por: Jiang, Wei, et al.
Publicado: (2021)

Four-miRNA signature as a prognostic tool for lung adenocarcinoma
por: Lin, Yan, et al.
Publicado: (2017)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2eum9kcifhg3sq0q9u2s5dqmqj